GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » EBITDA Margin %

Elixinol Wellness (ASX:EXL) EBITDA Margin % : -77.63% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Elixinol Wellness's EBITDA for the six months ended in Dec. 2023 was A$-3.74 Mil. Elixinol Wellness's Revenue for the six months ended in Dec. 2023 was A$4.81 Mil. Therefore, Elixinol Wellness's EBITDA margin for the quarter that ended in Dec. 2023 was -77.63%.


Elixinol Wellness EBITDA Margin % Historical Data

The historical data trend for Elixinol Wellness's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness EBITDA Margin % Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -261.78 -147.33 -151.20 -131.55 -82.71

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -89.97 -206.75 -68.56 -89.78 -77.63

Competitive Comparison of Elixinol Wellness's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's EBITDA Margin % falls into.



Elixinol Wellness EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Elixinol Wellness's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-6.839/8.269
=-82.71 %

Elixinol Wellness's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-3.737/4.814
=-77.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (ASX:EXL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Elixinol Wellness EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines